The goal of this study was to determine whether increases in cerebral venous pressure contribute to, and may account for, disruption of the blood-brain barrier during acute hypertension and hyperosmolar stimuli. We studied the relation between pial venous pressure and disruption of the blood-brain barrier during acute arterial hypertension, superior venae cavae occlusion, and superfusion with hyperosmolar arabinose. Sprague-Dawley rats were studied using intravital fluorescent microscopy and fluorescein-labelled dextran (mol. wt. = 70,000). Disruption of the blood-brain barrier was characterized by the appearance of microvascular leaky sites and quantitated by the clearance of fluorescein dextran. We measured pressure (servo null) in pial arterioles and venules 40-60 /xm in diameter. Acute hypertension, occlusion of the superior venae cavae, and hyperosmolar arabinose produced leaky sites primarily in venules. Acute hypertension increased arteriolar pressure and also venular pressure, from 7 ± 1 (mean ± SE) to 28 ± 2 mm Hg. Clearance of fluorescein dextran increased from 0.03 ±0.01 to 2.90 ± 0.40 ml/sec x 10"'. Occlusion of the superior venae cavae increased pial venous pressure from 7 ± 1 to 30 ± 3 mm Hg, and clearance of fluorescein dextran, from 0.02 ± 0.01 to 3.10 ± 0.59 ml/sec x 10*. In contrast to acute hypertension, there was a decrease in arterial and pial arteriolar pressure during occlusion of the superior venae cavae. Thus, similar Increases in venous pressure during acute hypertension and superior venae cavae occlusion, despite directlonally opposite changes in arterial and arteriolar pressure, produced similar disruption of the blood-brain barrier. Disruption of the blood-brain barrier during hyperosmolar arabinose was not associated with an increase in pial venous pressure. The findings suggest that 1) increases in pial venous pressure during acute hypertension are of sufficient magnitude to account for disruption of the blood-brain barrier, and 2) disruption of the blood-brain barrier during hyperosmolar arabinose is not associated with increases in pial venous pressure. (Circulation Research 1986;59:216-220)
related to increases in venular pressure and not related primarily to increases in arteriolar pressure. Acute hypertension produces an increase in sagittal sinus pressure. 6 -7 It is not clear, however, whether the increase in sagittal sinus pressure was associated with disruption of the BBB in veins or was sufficient in magnitude to account for disruption of the BBB. Without evaluation of the site of disruption and the ability of increases in venous pressure to produce disruption of the BBB, it is difficult to determine the importance of increases in sagittal sinus pressure, especially since arteriolar pressure also increases during acute hypertension.
Hyperosmolar solutions also disrupt the BBB in venules and veins. 5 -8 No studies have been conducted to determine the relation between disruption of the BBB and alterations in cerebral venous pressure during disruption of the BBB by a hyperosmolar solution.
Our first goal was to determine the relation between increases in cerebral venous pressure and disruption of the BBB. We used two new approaches. First, we measured venous pressure at the site of disruption during acute hypertension. Second, we attempted to determine whether increases in venous pressure were sufficient in magnitude to account for disruption of the BBB. To examine this possibility, we occluded the superior venae cavae to increase cerebral venous pressure to the same level as that observed during acute hypertension. We anticipated that, if increases in venous pressure were the primary mechanism of disruption of the BBB during acute hypertension, clearance of fluorescent dextran should be similar during acute hypertension and superior venae cavae occlusion. Our second goal was to determine whether disruption of the BBB during hyperosmolar arabinose was associated with increases in cerebral venous pressure.
Materials and Methods
Male Sprague-Dawley rats (n = 29) that weighed 350-400 g were anesthetized (pentobarbital sodium, 50 mg/kg, IP), and a tracheostomy was performed. The animals were mechanically ventilated with room air and supplemental oxygen. Skeletal muscle paralysis was obtained with gallamine triethiodide (15-30 mg/kg, IV).
A catheter was placed in a femoral vein for injection of drugs. A femoral artery was cannulated to obtain blood samples and to measure arterial pressure. In some animals, a bilateral thoracotomy was performed, and ligatures were placed around the superior venae cavae.
A craniotomy was made over the parietal cortex using methods we have described previously. 5 The window was superfused with artificial cerebral spinal fluid (pH = 7.35 ±0.01; Pco 2 = 41±l mm Hg; Po 2 = 75±5 mm Hg; temperature = 38°C). Blood gases were monitored and maintained within normal limits, (pH = 7.44 ±0.01; Pco 2 = 41±l mm Hg; Po 2 = 136 ±8 mm Hg).
Permeability of the Blood-Brain Barrier
Permeability of the BBB was evaluated as described previously. 3 Fluorescein isothiocynate (FTTC) labelled dextran (mol.wt. = 70,000) was injected intravenously. To prevent anaphylaxis to dextran, antihistamines (diphenhydramine, 10 mg/kg IV and cimetidine, 15 mg/kg TV) were injected 15 minutes prior to infusion of MlC-dextran. Macromolecular leakage during interventions was indicated by extravasation of FTTCdextran, which appeared as fluorescent spots or "leaky sites". We used measurements of suffusate and plasma concentration of HTC-dextran and suffusate flow rate to calculate the clearance (ml/sec X 10~6) of FTTCdextran by pial vessels.
Microvascular Pressure and Vessel Diameter
Pial arteriolar and venular pressure were measured with a micropipette connected to a servo null pressure measuring device (model 4A, Instrumentation for Physiology and Medicine). Pipettes (tip diameter of 2-4 fim) were sharpened, filled with 1.5 M NaCl, and inserted into the lumen of vessels (40-60 /u,m) using a micro-manipulator (Brinkman, Model no. MM-33). During normotension, the pipette was first inserted into an arteriole, then withdrawn and inserted into a venule. The pipette remained in the venule during acute hypertension. When pressure reached a steady state during acute hypertension (after approximately 3 minutes), the pipette was withdrawn from the venule and inserted into the original arteriole. All experiments were video recorded and diameters of vessels were measured using a video image shearing device (model 907, Instrumentation for Physiology and Medicine).
Experimental Protocol
In 9 rats, arterial pressure was increased by infusion of phenylephrine (10 /ig/min for 5 minutes, IV). Pressure and diameter of arterioles and venules was measured during control conditions and during infusion of phenylephrine. The location of leaky sites was determined at 5-minute intervals under control conditions and, during acute hypertension, at 2-minute intervals initially and then at 10-minute intervals for 40 minutes. Clearance of FTTC-dextran was determined at 5-minute intervals under control conditions, during acute hypertension, and for 40 minutes following acute hypertension.
In 3 rats, arterial pressure was maintained constant during infusion of phenylephrine by withdrawing blood. Leaky sites and clearance of FTTC-dextran were determined as described above.
In 2 rats, we cannulated the right atrium to measure right atrial pressure during acute hypertension.
In 7 rats, venous pressure was increased by occlusion of the superior venae cavae. Pressure and diameter of pial arterioles and venules were determined under control conditions and during occlusion of the superior venae cavae. Leaky sites and clearance of FTTC-dextran were determined as described above.
In 8 rats, osmotic disruption of the BBB was produced by superfusion of the pial vessels with 1.4 M arabinose for 5 minutes. Microvascular pressure and permeability of the BBB were determined under control conditions and during superfusion of arabinose.
Statistical Analysis
A paired t test was used to compare values within groups during control conditions and intervention. An unpaired t test was used to compare values between different groups. A p<0.05 was considered to be significant.
Results

Site of Disruption
Under control conditions, no leaky sites were visible. Acute hypertension disrupted the BBB initially in venules 25-40 yun in diameter. More diffuse leaky sites were observed in discrete areas of larger veins (>50 /im) within 5 minutes during acute hypertension. Occasionally, we observed diffuse extravasation of FTTC-dextran from arterioles (30-60 /wn) as well as from venules.
During superior venae cavae occlusion and hyperosmolar arabinose, disruption of the BBB was always venular. Leaky sites were not observed in arterioles or capillaries. Leaky sites occurred initially in venules 25-40 i*.m diameter. More diffuse leaky sites were observed in discrete areas of larger veins (>50 /xm) within 5 minutes during superior venae cavae occlusion and hyperosmolar arabinose. Figure 1 is a tracing from one experiment showing the effect of acute hypertension on arterial and pial venous pressure. Phenylephrine increased arterial pressure from 100 to 175 mm Hg in approximately 1.5 minutes. As arterial pressure increased, pial venous pressure increased from 6 to 30 mm Hg and became pulsatile. As pial venous pressure increased, we observed disruption of the BBB in venules.
Response to Acute Hypertension
When we infused phenylephrine and maintained arterial pressure constant, no leaky sites were visible and clearance of FTTC-dextran was minimal: 0.08 ± 0.01 during control conditions and 0.15 ±0.05 ml/sec X 10" 6 during phenylephrine (mean ± SE; p>0.05 using paired t test). Thus, effects of phenylephrine are mediated by the increase in arterial pressure, not by a direct effect of the drug.
Acute hypertension did not increase right atrial pressure significantly. Right atrial pressure was 1.3 ± 0.1 mm Hg during normotension (97 ± 2 mm Hg) and 1.8 ± 0.4 mm Hg during acute hypertension (181 ±2 mm Hg).
The effect of acute hypertension on cerebral arterioles and venules is shown in Table 1 . Under control conditions, pressure in arterioles approximately 40 /xm in diameter is only about 50% of arterial pressure. This finding suggests that approximately 50% of cerebral vascular resistance is accounted for by vessels greater than 40 /urn in diameter. Acute hypertension produced a significant increase in arteriolar pressure and diame-ter. Clearance of FTTC-dextran increased during acute hypertension. Values for clearance represent peak responses, which occurred 5 to 10 minutes after the onset of acute hypertension. Clearance of FTTC-dextran remained elevated 40 minutes following acute hypertension (2.55 ± 0.64 ml/sec x 10' 6 ;/J>0.05 versus peak response) even though venular pressure had returned to normal (6 ± 1 mm Hg). The new finding was that acute hypertension produced a significant increase in pial venular pressure and diameter (Table 1) . We then tested whether this increase in venous presure was sufficient in magnitude to account for disruption of the BBB during acute hypertension.
Response to Superior Venae Cavae Occlusion
Occlusion of the superior venae cavae produced significant decreases in mean arterial pressure and pial arteriolar pressure (Table 2) , presumably due to a decrease in venous return. This observation was in contrast to responses during acute hypertension. The diameter of pial arterioles increased, presumably an autoregulatory response to the decrease in arteriolar pressure. Pial venous pressure and diameter, and clearance of FTTC-dextran, increased during superior venae cavae occlusion. Clearance of FTTC-dextran remained elevated 40 minutes following superior venae cavae occlusion (2.56 ± 0.44 rruVsec X 10" 6 ;/?>0.05 versus peak response) even though venular pressure had returned to normal (6 ± 1 mm Hg).
The major finding was that, when pial venous pressure was increased by superior venae cavae occlusion to a level comparable to that observed during acute hypertension, clearance of FTTC-dextran was similar ( Figure 2 ). This finding suggests that the increase in pial venous pressure observed during acute hypertension was sufficient in magnitude to account for disruption of the BBB.
Response to Hyperosmolar Arabinose
Supervision of arabinose produced marked disruption of the BBB, which was not associated with an increase in venous pressure. Clearance of FTTC-dextran increased from 0.04 ± 0.01 to 3.31 ±0.58 ml/sec x 10~6 while venous pressure remained constant (6 ± 1 mm Hg). 
Discussion
There are three major new findings of this study. First, disruption of the BBB during acute hypertension is associated with an increase in pial venular pressure and diameter at the site of disruption. Second, the increase in pial venous pressure is sufficient to account for disruption of the BBB during acute hypertension. Third, disruption of the BBB during supervision of pial vessels with hyperosmolar arabinose is not associated with an increase in pial venous pressure. This finding indicates that increases in pial venous pressure and diameter are not associated with all stimuli that disrupt the BBB.
Consideration of Previous Studies
Investigators who have examined disruption of the BBB during acute hypertension and hyperosmolar solutions have focused on the role of cytoplasmic vesicles and endothelial tight junctions. 5910 Few studies have examined the role of microvascular pressure in disruption of the BBB by acute hypertension and no studies have been conducted to examine the role of microvascular pressure in osmotic disruption of the BBB.
Disruption of the BBB during acute hypertension occurs primarily in small venules. 5 Thus, we postulated that disruption in venules during acute hypertension may be closely related to increases in venular pressure. Auer et al 7 observed an increase in sagittal sinus pressure during acute hypertension in hypercapnic cats. Permeability of the BBB, and its relation to increases in sagittal sinus pressure, were not examined. Thus, it is not clear whether the increase in sagittal sinus pressure was sufficient to produce disruption of the BBB. In another study, Haggendal and Johansson 6 measured sagittal sinus pressure and disruption of the BBB to Evan's blue dye during rapid and gradual acute hypertension in cats. During rapid acute hypertension the capacity of cerebral arteries to autoregulate was surpassed, so that sagittal sinus pressure increased and the BBB was disrupted. During gradual acute hypertension, however, cerebral arteries autoregulated effectively, sagittal sinus pressure did not increase, and no disruption was observed. Again, no attempt was made to determine whether increases in sagittal sinus pressure were related to disruption in venules or sufficient to account for disruption in venules. Also, because arteriolar pressure, as well as venous pressure, increases during acute hypertension, one could not exclude a contribution of increases in arteriolar pressure to disruption of the BBB during acute hypertension.
Two new approaches in the present study allow us to extend the findings of previous studies. First, we measured pressure and diameter at the site of disruption, i.e., small venules. Second, we used superior venae cavae occlusion to determine whether increases in cerebral venous pressure, during acute hypertension, were sufficient in magnitude to account for disruption of the BBB. We found that disruption during acute hypertension was associated with a marked elevation of pial venular pressure and diameter. Experiments in which we occluded the superior venae cavae allowed us to dissociate changes in arteriolar pressure and venular pressure. During occlusion of the superior venae cavae, we observed increases in pial venular pressure that were similar to the increases during acute hypertension, but pial arteriolar pressure did not increase. More importantly, we observed a similar increase in clearance of FITC-dextran during superior venae cavae occlusion and acute hypertension, even though arteriolar pressure decreased during superior venae cavae occlusion. These findings are important in that they suggest that increases in venous pressure during acute hypertension are sufficient to account for disruption of the BBB.
Intracarotid or topical application of hyperosmolar solutions disrupt the BBB primarily in venules. 38 We examined the possibility that increases in pial venous pressure during hyperosmolar solutions may contribute to disruption of the BBB in venules. Hyperosmolar arabinose, however, did not increase pial venous pressure. This finding provides further evidence for the concept that the mechanism of disruption of the BBB is different during hyperosmolar solutions and during acute hypertension. 3 Disruption of the BBB during acute hypertension and superior venae cavae occlusion could be a transient response to increases in venous pressure, with increases in permeability that parallel increases in cerebral venous pressure, or a more prolonged effect which persists after venous pressure returns to normal. Data obtained 40 minutes following acute hypertension and superior venae cavae occlusion indicate that the BBB remains disrupted even though venous pressure was no longer elevated. It is possible that acute hypertension may initiate a prolonged, continued stimulus to disruption. This concept is supported by findings indicating that inhibitors of cyclooxygenase and free radicals reduce cerebral vascular damage produced by acute hypertension." Kontos 12 also has shown that production of free radicals during acute hypertension continues for at least 1 hour after pressure returns to normal. If disruption of the BBB during acute hypertension is mediated by oxygen radicals, our finding that disruption persists after venous pressure returns to normal is compatible with the finding that oxygen radicals are present for an extended period of time following acute hypertension.
Another possible interpretation of the finding that the BBB remains disrupted even though venous pressure had returned to normal is that increases in vesicular transport after acute hypertension may persist after removal of the stimulus. Nag et al 13 have shown that the number of pinocytotic vesicles containing horseradish peroxidase remained elevated during an 8 minute observation period following acute hypertension. Thus, the implications of the finding that permeability of the BBB remains elevated even though venous pressure had returned to normal levels are not clear but may suggest prolonged production of oxygen radicals or a persistent increase in vesicular transport.
Role of Veins
We have considered possible explanations for the finding that venules and veins are more susceptible than arterioles and capillaries to disruption of the BBB during acute hypertension and hyperosmolar arabinose. Studies in other vascular beds have shown that venules are the site of increased permeability during stimulation with histamine and bradykinin. 1415 This finding may be related to a greater density of receptor sites in venules for mediators of inflammation. 16 Also, oxygen radicals may play a role in disruption of the BBB in venules during acute hypertension. Previous studies" have not examined effects of acute hypertension on cerebral venules, but findings in other tissues 17 indicate that oxygen radicals increase microvascular permeability exclusively around post-capillary venules. Finally, venules less than 60 /nm in diameter do not have a layer of smooth muscle cells, whereas arterioles of similar diameter and smaller have a well developed layer of smooth muscle. 1 *" 21 Thus, one might predict that smooth muscle cells protect arterioles during acute hypertension. Our data are compatible with the concept. We found that disruption of the BBB during acute hypertension and occlusion of the superior venae cavae occurred primarily in venules and only rarely in arterioles.
In conclusion, we suggest that disruption of the BBB during acute hypertension occurs in venules and is associated with increases in pial venous pressure. More importantly, the increase in venous pressure is sufficient in magnitude to account for disruption of the BBB during acute hypertension. Finally, disruption during hyperosmolar arabinose is not associated with increases in venous pressure, which suggests that all stimuli that disrupt the BBB do not involve increases in venous pressure.
